Kotani, D., Bando, H., Masuishi, T., Komatsu, Y., Yamaguchi, K., Nakajima, T. E., Satoh, T., Nishina, T., Esaki, T., Nomura, S., Sakamoto, S., Iida, S., Matsuda, S., Yonemura, M., Fuse, N., Sato, A., Fujii, S., Ebi, H., Ohtsu, A., & Yoshino, T. (n.d.). 607TiPBIG BANG study: A multicenter phase II study of the MEK inhibitor binimetinib + BRAF inhibitor encorafenib + anti-EGFR antibody cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer (EPOC 1703). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095323526.0x000039